[{"Assets_0_Q2_USD":2023344000.0,"CommonStockSharesConverted_0_Q2_shares":55228000.0,"CommonStockSharesOutstanding_0_Q2_shares":55228000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":-292027000.0,"NetIncomeLossConverted_1_Q2_USD":-195782000.0,"NetIncomeLossConverted_2_Q2_USD":-360228000.0,"StockholdersEquity_0_Q2_USD":1636374000.0,"EarningsPerShareBasic_1_Q2_USD":-3.55,"EarningsPerShareBasic_2_Q2_USD":-6.54,"RevenuesConverted_1_Q2_USD":13296000.0,"RevenuesConverted_2_Q2_USD":25767000.0,"Ticker":"BLUE","CIK":"1293971","name":"BLUEBIRD BIO, INC.","OfficialName":"bluebird bio Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"301448421.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190801"}]